{"text": "Psychopharmacology, approximately 0.1% of patients taking Abilify experience\n\ntardive dyskinesia (3). Tardive dyskinesia is a condition characterized by\n\ninvoluntary movements of the face, lips, tongue, or other parts of the body.\n\nQT Interval Prolongation\n\nAbilify may increase the risk of QT interval prolongation, a rare but serious\n\nside effect. According to a study published in the Journal of Clinical\n\nPsychopharmacology, approximately 0.1% of patients taking Abilify experience", "embedding": []}